Utrecht University & MEB
Biopharmaceuticals have become important treatment options for a variety of chronic and life threatening diseases. As biopharmaceuticals have different characteristics than small molecules they may also have a different safety profile. This research will study challenges related to pharmacovigilance of biopharmaceuticals and therefore contribute to safe and efficacious treatment of patients with biopharmaceuticals.
Education and experience:
Lotte was trained as a pharmacist and obtained her PharmD degree in August 2016. As part of her Master program she did a 6-month research internship at the department of Pharmacoepidemiology and Clinical Pharmacology at Utrecht University. This project was focused on early detection of antipsychotic non-adherence. During her studies she worked for several years in a community pharmacy. Following graduation, she started her PhD project in September 2016. Lotte combines the PhD project with a position at the Dutch Medicines Evaluations Board where she works as a pharmacovigilance assessor.
Title PhD project:
Pharmacovigilance of biopharmaceuticals
PhD project description:
Previous research in this field also within the WHO Collaborating Centre for Pharmaceutical Policy and Regulation addressed several challenges related to pharmacovigilance of biopharmaceuticals that require further study. For example, traceability of biopharmaceuticals and the assessment of potential biopharmaceutical related adverse events.
Teammembers and other people involved: